CGM and Digital Education for Type 2 Diabetes
What You Need to Know Before You Apply
What is the purpose of this trial?
The current research study will add continuous glucose monitoring devices to the evidence-based text messaging diabetes education program for patients with type 2 diabetes for 6 months. Results on the effectiveness of this intervention will be compared for non-insulin using patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, it does mention that participants should not be using insulin therapies.
Is the CGM and Digital Education treatment safe for humans?
How does the Dulce Digital Text Messaging Intervention treatment differ from other treatments for type 2 diabetes?
The Dulce Digital Text Messaging Intervention is unique because it uses text messages to provide personalized education and support for managing type 2 diabetes, which is a low-cost and accessible method compared to traditional in-person consultations. This approach leverages the widespread use of mobile phones to deliver instant reminders and motivational messages, helping patients improve their diabetes self-management and outcomes.26789
What data supports the effectiveness of the treatment CGM Device, Dulce Digital Text Messaging Intervention for Type 2 Diabetes?
Research shows that personalized text messages can improve diabetes knowledge, self-care, and blood sugar control in people with type 2 diabetes. In one study, participants who received educational and motivational text messages saw significant improvements in their blood sugar levels and self-management skills.210111213
Who Is on the Research Team?
Athena Philis-Tsimikas, MD
Principal Investigator
Scripps Health
Are You a Good Fit for This Trial?
This trial is for patients with type 2 diabetes who do not use insulin. It's designed to see if adding a continuous glucose monitoring (CGM) device to a text messaging education program can help manage their condition over six months.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive continuous glucose monitoring devices and participate in a text messaging diabetes education program
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- CGM Device
- Dulce Digital Text Messaging Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Scripps Whittier Diabetes Institute
Lead Sponsor